Bolt Biotherapeutics, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold BOLT, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
6
Funds holding
$224727
Total value held
Buying
4 added/new · 0 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Pfizer Inc | $171176 | 31305 | — | Held |
| 2 | Blackrock, Inc. | $39233 | 9711 | — | Held |
| 3 | Morgan Stanley | $12883 | 3189 | +61 | +1.95% |
| 4 | Citigroup Inc | $1403 | 256 | — | NEW BUY |
| 5 | Barclays Plc | $24 | 6 | — | NEW BUY |
| 6 | Amalgamated Financial Corp. | $8 | 2755 | — | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.